TY - JOUR AU - Cook, R. J. AU - Farewell, V. T. PY - 1996 DA - 1996// TI - Multiplicity considerations in the design and analysis of clinical trials JO - J R Statistic Soc A VL - 159 UR - https://doi.org/10.2307/2983471 DO - 10.2307/2983471 ID - Cook1996 ER - TY - STD TI - Committee for Proprietary Medicinal Products: Points to consider on multiplicity issued in clinical trials. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003640.pdf. UR - http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003640.pdf ID - ref2 ER - TY - JOUR AU - Freidlin, B. AU - Korn, E. L. AU - Gray, R. AU - Martin, A. PY - 2008 DA - 2008// TI - Multi-arm clinical trials of new agents: some design considerations JO - Clin Cancer Res VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-08-0325 DO - 10.1158/1078-0432.CCR-08-0325 ID - Freidlin2008 ER - TY - JOUR AU - Jung, S. H. AU - George, S. L. PY - 2009 DA - 2009// TI - Between-arm comparisons in randomized Phase II trials JO - J Biopharm Stat VL - 19 UR - https://doi.org/10.1080/10543400902802391 DO - 10.1080/10543400902802391 ID - Jung2009 ER - TY - JOUR AU - Proschan, M. A. PY - 1999 DA - 1999// TI - A multiple comparison procedure for three- and four-armed controlled clinical trials JO - Stat Med VL - 18 UR - https://doi.org/3.0.CO;2-M DO - 3.0.CO;2-M ID - Proschan1999 ER - TY - JOUR AU - Schulz, K. F. AU - Grimes, D. A. PY - 2005 DA - 2005// TI - Multiplicity in randomised trials I: endpoints and treatments JO - Lancet VL - 365 UR - https://doi.org/10.1016/S0140-6736(05)66461-6 DO - 10.1016/S0140-6736(05)66461-6 ID - Schulz2005 ER - TY - JOUR AU - Chan, A. W. AU - Altman, D. G. PY - 2005 DA - 2005// TI - Epidemiology and reporting of randomised trials published in PubMed journals JO - Lancet VL - 365 UR - https://doi.org/10.1016/S0140-6736(05)71879-1 DO - 10.1016/S0140-6736(05)71879-1 ID - Chan2005 ER - TY - STD TI - Committee for Proprietary Medicinal Products: Note for guidance on choice of control group in clinical trials. http://www.emea.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002925.pdf. UR - http://www.emea.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002925.pdf ID - ref8 ER - TY - JOUR AU - Vermorken, J. B. AU - Parmar, M. K. AU - Brady, M. F. AU - Eisenhauer, E. A. AU - Hogberg, T. AU - Ozols, R. F. AU - Rochon, J. AU - Rustin, G. J. AU - Sagae, S. AU - Verheijen, R. H. PY - 2005 DA - 2005// TI - Clinical trials in ovarian carcinoma: study methodology JO - Ann Oncol VL - 16 ID - Vermorken2005 ER - TY - JOUR AU - Schulz, K. F. AU - Grimes, D. A. PY - 2005 DA - 2005// TI - Multiplicity in randomised trials II: subgroup and interim analyses JO - Lancet VL - 365 UR - https://doi.org/10.1016/S0140-6736(05)66516-6 DO - 10.1016/S0140-6736(05)66516-6 ID - Schulz2005 ER - TY - STD TI - Cochrane Handbook for Systematic Reviews of Interventions. Edited by: Higgins JPT, Green S. 2008, Chichester: Wiley ID - ref11 ER - TY - JOUR AU - Chan, A. W. AU - Hrobjartsson, A. AU - Haahr, M. T. AU - Gotzsche, P. C. AU - Altman, D. G. PY - 2004 DA - 2004// TI - Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles JO - JAMA VL - 291 UR - https://doi.org/10.1001/jama.291.20.2457 DO - 10.1001/jama.291.20.2457 ID - Chan2004 ER - TY - BOOK AU - Juszczak, E. AU - Altman, D. AU - Chan, A. W. PY - 2003 DA - 2003// TI - A review of the methodology and reporting of multi-arm, parallel group, randomised clinical trials (RCTs). 3rd Joint Meeting of the International Society for Clinical Biostatistics and Society for Clinical Trials ID - Juszczak2003 ER - TY - JOUR AU - Moher, D. AU - Dulberg, C. S. AU - Wells, G. A. PY - 1994 DA - 1994// TI - Statistical power, sample size, and their reporting in randomized controlled trials JO - JAMA VL - 272 UR - https://doi.org/10.1001/jama.1994.03520020048013 DO - 10.1001/jama.1994.03520020048013 ID - Moher1994 ER - TY - JOUR AU - Charles, P. AU - Giraudeau, B. AU - Dechartres, A. AU - Baron, G. AU - Ravaud, P. PY - 2009 DA - 2009// TI - Reporting of sample size calculation in randomised controlled trials: review JO - BMJ VL - 338 UR - https://doi.org/10.1136/bmj.b1732 DO - 10.1136/bmj.b1732 ID - Charles2009 ER - TY - JOUR AU - Boissel, J. P. PY - 2007 DA - 2007// TI - How to deal with multiple treatment or dose groups in randomized clinical trials? Another approach JO - Fundam Clin Pharmacol VL - 21 UR - https://doi.org/10.1111/j.1472-8206.2007.00478.x DO - 10.1111/j.1472-8206.2007.00478.x ID - Boissel2007 ER - TY - JOUR AU - Hothorn, L. A. PY - 2007 DA - 2007// TI - How to deal with multiple treatment or dose groups in randomized clinical trials? JO - Fundam Clin Pharmacol VL - 21 UR - https://doi.org/10.1111/j.1472-8206.2007.00469.x DO - 10.1111/j.1472-8206.2007.00469.x ID - Hothorn2007 ER - TY - JOUR AU - Proschan, M. A. AU - Waclawiw, M. A. PY - 2000 DA - 2000// TI - Practical guidelines for multiplicity adjustment in clinical trials JO - Control Clin Trials VL - 21 UR - https://doi.org/10.1016/S0197-2456(00)00106-9 DO - 10.1016/S0197-2456(00)00106-9 ID - Proschan2000 ER - TY - JOUR AU - Chan, A. W. AU - Upshur, R. AU - Singh, J. A. AU - Ghersi, D. AU - Chapuis, F. AU - Altman, D. G. PY - 2006 DA - 2006// TI - Research protocols: waiving confidentiality for the greater good JO - BMJ VL - 332 UR - https://doi.org/10.1136/bmj.332.7549.1086 DO - 10.1136/bmj.332.7549.1086 ID - Chan2006 ER - TY - JOUR AU - Hill, C. L. AU - LaValley, M. P. AU - Felson, D. T. PY - 2002 DA - 2002// TI - Discrepancy between published report and actual conduct of randomized clinical trials JO - J Clin Epidemiol VL - 55 UR - https://doi.org/10.1016/S0895-4356(02)00440-7 DO - 10.1016/S0895-4356(02)00440-7 ID - Hill2002 ER - TY - JOUR AU - Soares, H. P. AU - Daniels, S. AU - Kumar, A. AU - Clarke, M. AU - Scott, C. AU - Swann, S. AU - Djulbegovic, B. PY - 2004 DA - 2004// TI - Bad reporting does not mean bad methods for randomised trials: observational study of randomised controlled trials performed by the Radiation Therapy Oncology Group JO - BMJ VL - 328 UR - https://doi.org/10.1136/bmj.328.7430.22 DO - 10.1136/bmj.328.7430.22 ID - Soares2004 ER - TY - JOUR AU - Campbell, M. K. AU - Elbourne, D. R. AU - Altman, D. G. PY - 2004 DA - 2004// TI - CONSORT statement: extension to cluster randomised trials JO - BMJ VL - 328 UR - https://doi.org/10.1136/bmj.328.7441.702 DO - 10.1136/bmj.328.7441.702 ID - Campbell2004 ER - TY - JOUR AU - Moher, D. AU - Hopewell, S. AU - Schulz, K. F. AU - Montori, V. AU - Gotzsche, P. C. AU - Devereaux, P. J. AU - Elbourne, D. AU - Egger, M. AU - Altman, D. G. PY - 2010 DA - 2010// TI - CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials JO - BMJ VL - 340 UR - https://doi.org/10.1136/bmj.c869 DO - 10.1136/bmj.c869 ID - Moher2010 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1741-7015/11/84/prepub UR - http://www.biomedcentral.com/1741-7015/11/84/prepub ID - ref24 ER -